Semaglutide was approved for chronic weight management in non-diabetic patients (as Wegovy) based on STEP trial data showing sustained weight loss across BMI categories and metabolic profiles
The well-established healthcare infrastructure and widespread access to advanced medications like Semaglutide and Tirzepatide facilitated rapid adoption
Energy Balance and Metabolic Signaling AOD 9604 is also applied in studies examining broader energy metabolism and substrate utilization
Available from: Luckett AM, Hawkes G, Green HD et al (2025) Type 1 diabetes genetic risk contributes to phenotypic presentation in monogenic autoimmune diabetes
Recommended Safe Dosage While there is no universal standard dose, typical safe dosage ranges in the industry vary by application: Health Supplements: Most oral formulations range from 250 mg to 1,000 mg per day
The reconstituted peptides should be stored in a refrigerator, at a temperature level ranging from 2 to 8 degrees C